Clinical, pharmacokinetic and pharmacodynamic data for the MEK1/2 inhibitor pimasertib in patients w...
Clinical, pharmacokinetic and pharmacodynamic data for the MEK1/2 inhibitor pimasertib in patients with advanced hematologic malignancies
About this item
Full title
Clinical, pharmacokinetic and pharmacodynamic data for the MEK1/2 inhibitor pimasertib in patients with advanced hematologic malignancies
Author / Creator
Ravandi, F , Pigneux, A , DeAngelo, D J , Raffoux, E , Delaunay, J , Thomas, X , Kadia, T , Kantarjian, H , Scheuenpflug, J , Zhao, C , Guo, W and Smith, B D
Publisher
London: Nature Publishing Group UK
Journal title
Blood cancer journal (New York), 2015-12, Vol.5 (12), p.e375-e375
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Alternative Titles
Full title
Clinical, pharmacokinetic and pharmacodynamic data for the MEK1/2 inhibitor pimasertib in patients with advanced hematologic malignancies
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4735070
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4735070
Other Identifiers
ISSN
2044-5385
E-ISSN
2044-5385
DOI
10.1038/bcj.2015.103
